Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule

The purpose of present study is to provide clinical evidences for the appropriate management of molar pregnancy with lung nodule. The hydatidiform mole patients with lung nodule ≥1.0cm will be randomized into 2 groups: A. treated with chemotherapy immediately, B. follow up until hCG level met FIGO diagnostic criteria of GTN (B1) or hCG level declined to normal spontaneously (B2). Lung nodule \<1.0cm will directly treated as group C

Trial Details

NCT ID
NCT03785574
Phase
NA
Sponsor
Women's Hospital School Of Medicine Zhejiang University
Status
RECRUITING
Cancer Type
Lung Cancer
Interventions
  • Follow up
  • chemotherapy
Locations (sample)
  • Hangzhou, Zhejiang, China|30.29365,120.16142

Key Eligibility Criteria

  • Eligible patients have to meet all of the following criteria:
  • Pathologically confirmed HM.
  • The lung nodules are detected by lung CT and metastatic lesions could not be excluded (before or after the suction dilation and curettage).
  • The hCG level does not meet FIGO diagnostic criteria (2018) of GTN.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lung Cancer Trials on Trialify →